Literature DB >> 34969069

Causal inference for semi-competing risks data.

Daniel Nevo1, Malka Gorfine1.   

Abstract

The causal effects of Apolipoprotein E $\epsilon4$ allele (APOE) on late-onset Alzheimer's disease (AD) and death are complicated to define because AD may occur under one intervention but not under the other, and because AD occurrence may affect age of death. In this article, this dual outcome scenario is studied using the semi-competing risks framework for time-to-event data. Two event times are of interest: a nonterminal event time (age at AD diagnosis), and a terminal event time (age at death). AD diagnosis time is observed only if it precedes death, which may occur before or after AD. We propose new estimands for capturing the causal effect of APOE on AD and death. Our proposal is based on a stratification of the population with respect to the order of the two events. We present a novel assumption utilizing the time-to-event nature of the data, which is more flexible than the often-invoked monotonicity assumption. We derive results on partial identifiability, suggest a sensitivity analysis approach, and give conditions under which full identification is possible. Finally, we present and implement nonparametric and semiparametric estimation methods under right-censored semi-competing risks data for studying the complex effect of APOE on AD and death. © he Author 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; Bounds; Frailty model; Illness-death model; Principal stratification

Mesh:

Substances:

Year:  2022        PMID: 34969069      PMCID: PMC9566449          DOI: 10.1093/biostatistics/kxab049

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.279


  19 in total

1.  Principal stratification in causal inference.

Authors:  Constantine E Frangakis; Donald B Rubin
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  Principal stratification--uses and limitations.

Authors:  Tyler J Vanderweele
Journal:  Int J Biostat       Date:  2011-07-11       Impact factor: 0.968

3.  Reflection on modern methods: causal inference considerations for heterogeneous disease etiology.

Authors:  Daniel Nevo; Shuji Ogino; Molin Wang
Journal:  Int J Epidemiol       Date:  2021-07-09       Impact factor: 7.196

4.  Mediation analysis for a survival outcome with time-varying exposures, mediators, and confounders.

Authors:  Sheng-Hsuan Lin; Jessica G Young; Roger Logan; Tyler J VanderWeele
Journal:  Stat Med       Date:  2017-08-15       Impact factor: 2.373

5.  Dementia and Alzheimer disease incidence: a prospective cohort study.

Authors:  Walter A Kukull; Roger Higdon; James D Bowen; Wayne C McCormick; Linda Teri; Gerard D Schellenberg; Gerald van Belle; Lance Jolley; Eric B Larson
Journal:  Arch Neurol       Date:  2002-11

6.  APOE genotype and survival in men and women with Alzheimer's disease.

Authors:  G Dal Forno; K A Carson; R Brookmeyer; J Troncoso; C H Kawas; J Brandt
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

7.  Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected Postrandomization.

Authors:  Bryan E Shepherd; Peter B Gilbert; Thomas Lumley
Journal:  J Am Stat Assoc       Date:  2007-06       Impact factor: 5.033

8.  Modeling semi-competing risks data as a longitudinal bivariate process.

Authors:  Daniel Nevo; Deborah Blacker; Eric B Larson; Sebastien Haneuse
Journal:  Biometrics       Date:  2021-05-18       Impact factor: 1.701

Review 9.  ApoE4: an emerging therapeutic target for Alzheimer's disease.

Authors:  Mirna Safieh; Amos D Korczyn; Daniel M Michaelson
Journal:  BMC Med       Date:  2019-03-20       Impact factor: 8.775

10.  Identification and estimation of survivor average causal effects.

Authors:  Eric J Tchetgen Tchetgen
Journal:  Stat Med       Date:  2014-05-29       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.